RaNA acquires mRNA platform from Shire

RaNA Therapeutics Inc. (Cambridge, Mass.) said it acquired the MRT mRNA therapeutic platform from Shire plc (LSE:SHP; NASDAQ:SHPG). The platform enables mRNA

Read the full 228 word article

User Sign In